Hansa Biopharma to host conference call to provide interim results for January-September 2021 and Business Update

/PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-September 2021 at 8:00 CET on October 21, 2021. All...

Related Keywords

United States ,Copenhagen ,Køavn ,Denmark ,Stockholm ,Sweden ,United Kingdom ,Tulstrup ,Hovedstaden ,London ,City Of ,San Francisco ,California ,Hansa Biopharma ,Prnewswire Hansa Biopharma ,Klaus Sindahl ,Donato Spota ,Katja Margell ,Wainwright Bioconnect ,Head Of Corporate Communications ,Nasdaq Stockholm ,Ugebrev Life Science Conf ,Redeye Life Science Day ,Jefferies Global Healthcare Conference ,Erik Penser Banks Bolagsdag ,Geneva European Midcap ,Carnegie Healthcare Seminar ,Corporate Communications ,Hansa Biopharma Ab ,